Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April Killikelly

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Vaccine|March 13, 2025
Immunogenicity of pre-exposure rabies vaccination comparing number of doses and routes of administration: A systematic review and meta-analysesPhaedra Davis, Joshua Montroy, Bryna Warshawsky, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 21, 2024
Burden of disease of respiratory syncytial virus in infants, young children and pregnant women and peopleElissa M Abrams, Pamela Doyon-Plourde, Phaedra Davis, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|January 9, 2025
Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infectionElissa M Abrams, Pamela Doyon-Plourde, Phaedra Davis, et al.
Biochemistry|August 16, 2013
Thermodynamic signatures of the antigen binding site of mAb 447-52D targeting the third variable region of HIV-1 gp120April Killikelly, Hui-Tang Zhang, Brett Spurrier, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 14, 2020
Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreatApril Killikelly, Amanda Shane, Man Wah Yeung, et al.
Journal of Bacteriology|October 22, 2014
Structure-based functional characterization of repressor of toxin (Rot), a central regulator of Staphylococcus aureus virulenceApril Killikelly, Meredith A Benson, Elizabeth A Ohneck, et al.
The Journal of Biological Chemistry|August 31, 2010
Structural basis of cyclophilin B binding by the calnexin/calreticulin P-domainGuennadi Kozlov, Sara Bastos-Aristizabal, Pekka Määttänen, et al.
Vaccine|July 30, 2024
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infantsGebremedhin B Gebretekle, Man Wah Yeung, Raphael Ximenes, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 9, 2024
Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysisAshleigh R Tuite, Alison E Simmons, Monica Rudd, et al.
Vaccine: X|November 18, 2024
COVID-19 vaccine evidence monitoring assisted by artificial Intelligence: An emergency system implemented by the Public Health Agency of Canada to capture and describe the trajectory of evolving pandemic vaccine literatureSu Hyun Lim, Mona Hersi, Ramya Krishnan, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Vaccine|March 13, 2025
Immunogenicity of pre-exposure rabies vaccination comparing number of doses and routes of administration: A systematic review and meta-analysesPhaedra Davis, Joshua Montroy, Bryna Warshawsky, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 21, 2024
Burden of disease of respiratory syncytial virus in infants, young children and pregnant women and peopleElissa M Abrams, Pamela Doyon-Plourde, Phaedra Davis, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|January 9, 2025
Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infectionElissa M Abrams, Pamela Doyon-Plourde, Phaedra Davis, et al.
Biochemistry|August 16, 2013
Thermodynamic signatures of the antigen binding site of mAb 447-52D targeting the third variable region of HIV-1 gp120April Killikelly, Hui-Tang Zhang, Brett Spurrier, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 14, 2020
Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreatApril Killikelly, Amanda Shane, Man Wah Yeung, et al.
Journal of Bacteriology|October 22, 2014
Structure-based functional characterization of repressor of toxin (Rot), a central regulator of Staphylococcus aureus virulenceApril Killikelly, Meredith A Benson, Elizabeth A Ohneck, et al.
The Journal of Biological Chemistry|August 31, 2010
Structural basis of cyclophilin B binding by the calnexin/calreticulin P-domainGuennadi Kozlov, Sara Bastos-Aristizabal, Pekka Määttänen, et al.
Vaccine|July 30, 2024
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infantsGebremedhin B Gebretekle, Man Wah Yeung, Raphael Ximenes, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 9, 2024
Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysisAshleigh R Tuite, Alison E Simmons, Monica Rudd, et al.
Vaccine: X|November 18, 2024
COVID-19 vaccine evidence monitoring assisted by artificial Intelligence: An emergency system implemented by the Public Health Agency of Canada to capture and describe the trajectory of evolving pandemic vaccine literatureSu Hyun Lim, Mona Hersi, Ramya Krishnan, et al.
Pageof 3